
About Gydantis Pharmaceuticals LLP
Data last updated:
Gydantis Pharmaceuticals LLP is a limited liability partnership (LLP) based in Rohini, Delhi, India, recognised as a startup by DPIIT. It operates in the chemicals and chemical products segment of the chemicals sector. It was incorporated on 04 January 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAV-3365.
The LLP has a total obligation of contribution of βΉ1 Lakh. It is led by designated partners Anuj Kumar Handa and Neelam Singh.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Garage No 200 Block C Gh 4 Rohini Heights Apartment Sector 2, 9, Delhi, India β 110082.
Gydantis Pharmaceuticals LLP is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-04-0020114). For more details, the LLP can be reached via its website gydantis.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGarage No 200 Block C Gh 4 Rohini Heights Apartment Sector 2, 9, Delhi, India β 110082
- IndustryChemicals, Chemicals and Chemical Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Designated Partners of Gydantis Pharmaceuticals LLP
Gydantis Pharmaceuticals has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuj Kumar Handa | Designated Partner | 04 Jan 2021 | 5 Years 9 Months | Current |
| Neelam Singh | Designated Partner | 04 Jan 2024 | 2 Years 9 Months | Current |
Financials of Gydantis Pharmaceuticals LLP FY 2025 filings available
Financial Statement Summary of Gydantis Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gydantis Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Gydantis Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gydantis Pharmaceuticals LLP
Gydantis Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Gydantis Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Gydantis Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Gydantis Pharmaceuticals LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Gydantis Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gydantis Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gydantis Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gydantis Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Gydantis Pharmaceuticals LLP
Frequently Asked Questions about Gydantis Pharmaceuticals LLP
Gydantis Pharmaceuticals is an active limited liability partnership based in Rohini, Delhi, India. The LLP works in chemicals and chemical products, within the chemicals industry. It was incorporated on 04 January 2021 (5+ years old) and is registered under LLPIN AAV-3365.
Gydantis Pharmaceuticals has 2 current designated partners:
- Anuj Kumar Handa - Designated Partner
- Neelam Singh - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Gydantis Pharmaceuticals is AAV-3365. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Gydantis Pharmaceuticals was incorporated on 04 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Yes, Gydantis Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Gydantis Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-DL-04-0020114).
Gydantis Pharmaceuticals can be reached through the website gydantis.com. Its registered office is in Rohini, Delhi, India.
The registered office of Gydantis Pharmaceuticals is at Garage No 200 Block C Gh 4 Rohini Heights Apartment Sector 2, 9, Delhi, India β 110082.
The total obligation of contribution is βΉ1 Lakh.